|
| |
|
Vaccination Time Line
|
CAUTION …This Timeline
is based Solely on Facts and History
What ever
conclusions you come to, are strictly your own |
1578
The 1st recognized description of Whooping cough by Dr. Guilluame Bailou
in France. The lung is so irritated that, in its attempts by every
effort to cast forth the cause of the trouble, it can neither admit
breath nor easily give it forth again. The sick person seems to swell up
as it is about to strangle, holds it breath coughing sometimes for space
of 4 or 5 hours, than the paroxysm of coughing returns, …it was
resistance to every medicine. The cough was very fatiguing, upset the
stomach and caused vomiting; or it shattered the veins of the brain,
causing blood to spurt forth in hemorrhages. These stopped for several
days, but in July and August they returned, more violent than ever and
attached children primarily.
1694
Queen Mary II of England dies of small pox. More than 60 million people
in Europe would die from small pox during the next decade.
1721
Boston, Zabdiel inoculated his only son with small pox and was mobbed by
angry citizens denouncing his action.
1796
Edward Jenner, British physician noted that dairy maids who had caught
“cowpow” (a minor disease) could not catch small pox (a major disease).
1798
Edward Jenner introduced the practice of vaccinations by inoculating a
boy with cowpox pus and demonstrating that, when subsequently
inoculating with smallpox pus, he did not come down with the disease.
1853
England passes a compulsory vaccine law for smallpox.
1904
A Supreme Court decision removed individual rights to refuse vaccine
immunizations.
1912
The 1st whooping cough vaccine was created by French bacterists Jules
Bordet & Octave Gengou.
1915 – 1958
Greater than a 95% decline in measles was documented, long before the
measles vaccine was introduced.
1923-1925
Danish researcher, Thorvaid tried out a modified pertussis vaccine
during a whooping cough epidemic in the Faroe Islands. He vaccinated
babies and while it did not prevent whooping cough, it appeared to make
the disease milder and reduced the number of deaths.
1930’s – 1940’s
Scientist and Doctor’s try to defend the best possible way to make the
vaccine and keep it safe along with the best age for administrating the
1st shot and whether to combine it.
1933
The 1st death associated with the pertussis vaccine was documented by
Thorvaid Madsen in Copenhagen.
1936
Pertussis becomes available in the United States.
1938
Baltimore, Maryland – a 5 year old boy was brought to the John Hopkins
University to see child psychiatrist, Leo Kanner.
Late 1930’s
American researchers reported that some children reacted with fevers,
convulsions and collapse. But, most Doctor’s discounted those reports
convinced that reactions were insignificant compared to the protection
that vaccine gave them against whooping cough.
1940
Pertussis is put
into general use in the United States.
1941
Louis Sauer developed his own pertussis vaccine and urged that pertussis
vaccines begin no earlier than 7 months of age.
1942
Louis A. Lurie MD and Soy Levy MD reported at an AMA that whooping
cough, which had long been recognized as a cause of brain damage, may
also through a less dramatic but equally serious injury to the brain,
causing a wide variety of behavior disturbances. There appears to be a
definite relationship between the neurological sequence of the whooping
cough and the behavior disorders and personality changes shown …in later
life.
1943
Alum or alum-based substances were added to the vaccine.
1945
First autistic child reported in Japan.
1946
Kendrick and Pittman hit upon the idea of challenging or exposing
vaccinated mice to whooping cough by injecting the challenging doses of
pertussis bacteria directly into their brains. The vaccine’s ability to
protect against whooping cough (potency or efficacy) was judged by how
many mice survived and how many died after being infected with the
disease.
Were & Garrow described the deaths of identical twins who died within 24
hours of their 2nd shot.
Douglas Buchanan MD, a professor of neurology at the University Of
Chicago School Of Medicine, called attention to a neurological disorder
which he believed was often misdiagnosed. He wrote, "a type of major
convulsions in young infants which is frequently not recognized as such
is one in which there is a sudden forward dropping of the head with
adduction and flexion of the arms. These attacks are extremely brief and
tend to occur in bursts. They are really “lightening major convulsions”.
They are more common in children less than 2 years old. They are
notoriously difficult completely to control and are most often found in
association with severe degrees of cerebral agencies and mental
retardation.”
Late 1940’s
Government, Health Officials and Physicians were aggressively promoting
pertussis vaccination throughout America as the incidence of whooping
cough was highly declining.
1948
A correlation
between diet and polio is discovered.
The Prevention Vaccine Law of 1948 was enacted making it a legal
requirement for children to be inoculated in Japan. It was adopted by
the order of the American Occupational Army. Vaccinations were to begin
at 3 months.
Randolph K. Byers & Fredick C. Moll of Harvard Medical School published
an article describing children who had suffered brain damage after
receiving the pertussis vaccine. Their findings shocked the medical
community and provide clear substantiation that the vaccine caused
serious neurological complications in children.
Louis Sauer made an observation after Toomey presented his report in
1949 (Beyer and Moll study) pointing out that neurological damage caused
by vaccine resembles the damage caused by whooping cough.
1949
The Division of Biologics Standards (DBS) of the Public Health Service
established a national potency test and modified it in 1953 to establish
maximum & minimum policy limits.
1950’s
Europe received the pertussis vaccine.
Pertussis is in full swing in the Unites States
The National Institute of Health was well aware that the Salk vaccine
was ineffective and deadly. Salk was quotes as saying, “when you
inoculate your child, you don’t sleep well for 2 to 3 weeks.”
1953
S. Kong MD, of the pediatric clinic of the University of Zurich,
compiled a list of 82 cases.
Polio death rate in the United States and England decreased by 47-55%.
Stats declined in Europe as well.
1954
Miller and Straton described the case of a baby girl who reacted to her
3rd DPT shot. “Seven days after her 3rd injection on a combined
diphtheria-pertussis vaccine, this previously healthy baby developed a
severe attack of screaming followed by drowsiness. During the subsequent
2 days the child remained alternately drowsy and restless, though she
was able to take her food. At the end of this period the parents noticed
that she was not moving her right arm and leg. Examination revealed a
right hemiplegia involving face, arm and leg. Two years later, right
hemiparesis persists. There is difficulty in using the right hand, but
the child can walk. General development and intelligence appears to be
unimpaired.
1954 – 1965
The manufactured vaccine is subject to the toxicity test developed and
refined by Pittman and others at the DBS. This test is supposed to
measure the vaccines safety, meaning how likely is it to cause severe
reactions in children? This was plagued with problems. When Pittman
tried to redefine it in the late 1950’s, some mice seemed to gain weight
over a period of time. If the mice do not die and continue to gain a
specific amount of weight, vaccine manufacturers and the FDA consider
the vaccine safe for children.
1955
Neils Loos of the Department of Neurology, University of Illinois School
of Medicine showed that the EEG of infants sometimes was altered by the
DPT shot. He concluded that, “mild, but possibly significant, cerebral
reactions occur in addition to the reported very severe neurological
changes.” In spite of these warnings, Doctor’s continued to insist that
the small damage caused by the pertussis vaccine was offset by the lack
of serious reactions in the hundreds of thousands of infants who were
regularly vaccinated. But upon what evidence did they base this
assumption?
Dr. Jonas Salk, American Physician & Microbiologist developed a “killed
virus” against Polio.
Albert Sabin also an American Physician and Microbiologist developed a
“live-viral” (oral) vaccine against polio. Natural polio virus produces
no symptoms at all in 90% of the people exposed to it, even under
epidemic conditions.
1957
William Landau and Frank Kleffner discover the 1st case of Landau-Kleffner
Syndrome.
Parke-Davis decided to combine the new Salk polio vaccine with the
existing DPT vaccine, Triogen. The new product called Quadrigen, was
licensed by the Government in July of 1959. When it was withdrawn from
circulation from the market 9 years later, more than 8 million doses had
been injected into nearly 3 million babies.
Late 50’s
Pertussis is promoted on a large scale in England.
1960
The Massachusetts Department of Public Health found that Quadrigen was
not passing the states potency tests. The company’s response was to
abruptly increase the number of pertusis bacteria per unit of the
vaccine. This was an almost incomprehensible step, since it meant
changing the composition of the vaccine after the license had already
been issued.
1961
J.M.H. Hooper, a senior medical officer in Northern England, found that
some parents were refusing to bring their children into local health
clinics for further DPT shots. He investigated and found the reason to
be occasional violent reactions to a previous shot. No one paid
attention to this.
1963
A team of Scientist’s headed by John F. Enders created a measles
vaccine. Mass inoculation would soon follow.
1964
The Cude vs. Arkansas case reinforced the 1904 United States Supreme
Court decision that States have the right to enforce mandatory
vaccination laws.
1965
Margaret Pitman, the US leading pertussis vaccine expert states,
Bordetella pertussis is unique among infectious bacteria in its marked
ability to modify biological responses. Therefore, there has been
special concern that pertussis vaccine is as free as possible from
reactive factors and yet provides adequate protection against whooping
cough.
The United States Congress passed the Immunization Assistance Act
setting up categorical grant program to States and large Metropolitan
areas to establish immunization programs.
Mid 1960’s
Many States had laws requiring DPT and Polio vaccinations, most of them
ensuring compliance by making the vaccination requirement mandatory for
entry into elementary school.
1967
Strom wrote that his earlier article on averse reactions had aroused,
“considerable attention and also criticism,” but insisted that the
convulsions , shock and abnormal irritability observed after the triple
vaccination cannot always be regarded as common place general symptoms
but rather reflect an objectively demonstrable cameral reaction. The
vaccination reactions may be regarded chiefly as manifestations of a
toxic effect, an individual predisposition being of some significance.
1968
Quadrigen was withdrawn from the market due to the fact it was highly
reactive in small children.
1969
Dr. Charlotte Hannik found a history of allergies in 20 of the 35
children who reacted with persistent screaming, shock/collapse, or
convulsions to the DPT-Pertussis vaccinations.
1970
A vaccine against Hepatitis was developed and made available.
1971
MRI (tri-valent measles/mumps/rubella) vaccine is licensed.
1972
Ribcoff Senate hearings – the DBS was transferred from the Public Health
Service (PHS) to the Food and Drug Administration where it became the
Bureau of Biologics (B)B) headed by Harry Meyer.
USA ends the practice of routine smallpox vaccine.
1974
Estimated in Britain were 80 cases of severe neurological complications
annually; 1/3 of these children died, and 1/3 were left with residual
brain damage. They admitted to being, “not entirely convinced that the
community benefits from whooping cough and vaccination outweighs the
damage it may be doing.”
1975
Japan pulls the Pertussis off the market following publicity about two
Pertussis related vaccine deaths. Japan comes back later that year and
introduces another vaccine, one that is less toxic. This time
inoculation will not begin until the age of two.
World Health Organization (WHO) sponsored an International meeting on
Pertussis vaccine experts. They recommended that “children from families
with a history of neurological disorders should not be vaccinated.”
Vaccine lot #1182 was sent to the FDA for routine testing prior to
release. The FDA found that lot #1182 was three times more potent than
the regulations allowed and refused to allow the State of Michigan to
distribute it outside the State. Rather than immediately destroy the
infective lot, which represented about 400,000 doses, Michigan health
officials decided to see just how reactive it was by testing it on
several hundred children in Ingham County. To date, court records show
that at least three children injected with vaccine from lot #1182
suffered reactions which left them with seizures, paralysis and brain
damage. The parents sued the Michigan Department of Public Health,
describing the Department’s use of the vaccine as “potentially lethal
misconduct and showing callous disregard for human life.”
The flu vaccine is made available; more than 500 people were paralyzed
with Guillian Bare Syndrome.
Dr. Jonas Salk testified that the live-virus vaccine (used almost
exclusively in the United States since the 1960’s was the “principal
cause, if not sole cause of all reported cases of polio in the United
States.”
Charles Manclark,
FDA Pertussis specialist states, “Pertussis vaccine is one of the more
troublesome products to produce and assay. As an example of this,
Pertussis vaccine has one of the highest failure rates of all products
submitted to the Bureau of Biologitics for testing and release.
Approximately 15 to 20 percent of all lots which pass the manufacturer’s
tests fail to pass the Bureau’s test.”
1976
West Germany ends its mass pertussis immunization program.
1997
Gordon T. Stewart MD, of the Department of Community Medicine,
University of Glasgow in Scotland, published a study analyzing 160 cases
of adverse reactions and neurotoxicity following DPT vaccinations. He
reported that in 65 children, reactions were “followed by convulsions,
hyperkinesias (hyperactivity) and severe mental defect.” He concluded,
“It seems likely that most adverse reactions are unreported and that may
be overlooked.”
Austria and Southern German introduced a new oral vaccine by Behring
Laboratories in Vienna. This is given to new borns while they are still
in the hospital. It is inserted into their nasal passages. To date there
have been no reported side effects.
1978
Griffith studied severe reactions occurring after 15 million doses of
the pertussis vaccine were administered to children in England. He
stated that one child “was admitted to the hospital with prexia signs
and symptoms of meningeal irritation, transferred after three days with
provisional diagnosis of encephalomyelitis , but died 30 days after
vaccination; necropsy showed no specific changes. Recorded cause of
death was encephalopath due to injection of the triple vaccine.”
1979
Rubella vaccine was introduced.
The Swedish Government withdrew support from the pertussis vaccine
because authorities were beginning to doubt it’s effectiveness in
controlling whooping cough and were worried about a large number of
serious reactions. The vaccine had been changed and the toxicity had
been altered. Thereafter, the incidence of whooping cough rose almost to
revaccination levels.
The United States Food and Drug Administration funded a study
representing the 1st large scale attempt in the Unite States government
to evaluate reactions to the DPT shot. The study conducted at the
University of California in Los Angeles, was co-authored by Cody Baraff,
Cherry Marcy and FDA pertussis vaccine researcher, Charles Manclark
Ph.D. and published in Pediatrics in 1981.
California Physicians, Jack Jacok and Frank Manning wrote in the
American Journal
of the Diseases of
children about the case of a child who experienced a “building fontanel
associated with increases intra cranial pressure as measured by the
lumbar puncture,” within 24 hours of the DPT shot. This 7 month old girl
who was the daughter of an Pediatrician, began running a high fever
after her third DPT shot and nine hours later, her parents noticed the
soft spot on her head was bulging and pulsating. He became irritable and
also had redness and swelling on the site injection. She was admitted to
the hospital and although the tests came back negative, the bulging did
not stop until after 40 hours after the shot. The Doctor’s concluded,
“The clinical symptom logy in this patient, consisting of fever and
irritability are symptoms frequently associated with DPT immunization.
The bulging fontanel was accidentally noted by the child’s parents who
recognized its importance. It is therefore, conceivable that this
complication may be missed unless specifically looked for.”
Barkin and Pichichero in Colorado reported a very high proportion of
unusual symptoms. In their study, only seven percent of the parents
reported no reactions. Twenty seven percent reported mild reactions and
fifty nine percent reported moderate reactions while seven percent
reported severe reactions.
1980
West German Physician Wolfgang Ehrengut suggested in one of his studies
that Doctor’s have a negative bias against vaccine reactions, and UN
willingness to believe, because “what must be not true, therefore,
cannot be.” It must be true, for whatever will they do if it is not?
1981
“Acelluer Pertussis - DTaP,” (Japanese pertussis) is a new vaccine in
introduced in Japan. They claim it is less toxic and more effective.
D.L. Miller MD, and others published and analysis of the 1st one
thousand cases of neurological illness reported to the health officials
conducting the NCES. Thirty five of these cases had received the
pertussis vaccine within seven days of becoming ill. The author’s
concluded, “A significant association was shown between serious
neurological illness and pertussis vaccine.”
The British National Childhood Encephalopath Study (NCES), found a
statistical correlation between the DPT shot and neurological illness
occurring within seven days of the shot.
1982
FDA Symposium, a Japanese scientist pointed out that the toxic
substances produced by the “B pertussis,” may not be responsible for the
neurological complications of whooping cough, as well as those of the
vaccine which contains the ’B’ pertussis.”
The television broadcast in the United States: “DPT; Vaccine Roulette,”
the microbiologists Bobby Young said, “If a child is not frankly
rendered a vegetable, …how
many infants that are receiving this are in some way damaged by the
vaccine, and how can you proved they haven’t been, or they have been?
All of them have been vaccinated.” Young was critized by physicians in
positions of leadership in the American medical establishment and the
FDA for making these statements. “The number of well children who have
suffered mental or physical disturbance as a result of vaccination may
have to be counted not in the hundreds, as in the United States or in
thousands all over the world. This is a heavy price to pay for a disease
that seldom nowadays threatens the life or health of our children.”
Shortly after that broadcast aired, a group of parents band together and
form Dissatisfied Parents Together (DPT)/ Their goal is to gather
vaccine information about the pertussis, get information out to parents
and find ways to lesson pertussis vaccine damage.
1983
Larry Baraff MD, who was the principal author of the UCLA-FDA study
published in the USA in 1979 and August of 1980 said fifty three percent
of children who received a DPT immunization, six died within twenty four
hours and eleven more died seven days of the DPT shot.
Senator Paul Hawkins (R-FL) introduced the National Child Vaccine Injury
Act (S-2117) in November.
Lawrence Steinman MD, Stanford University and London Hospital published
a study in Nature suggesting that some children with allergies may be
genetically predisposed to reacting to the pertussis vaccine. The
susceptibility to the “B” pertussis immunization in humans may be
controlled by genes. The possibility that adverse reactions to routine
immunization may be under genetic seems novel. There is clearly a
connection between allergies, especially milk allergies and the tendency
to react severely to pertussis vaccines. The vaccine interacts with the
mechanisms in the body that are involved in allergy and
hypersensitivity.
1984
Merck Sharp and Dohme announced the creation of a chicken pox vaccine
that it hopes to make available to the American public in several years.
However, concern about the possibility that the vaccine might have side
effects including Rye Syndrome, an occasional complication of chicken
pox disease and influenza, as well as delayed effects that do not appear
for years, has been expressed by several observers.
1985
The HIB (Hemophilus influenza B) is taken off the market due to safety
and efficacy reasons.
1986
The passage of the National Vaccine Injury Act of 1986. All physicians
administrating vaccines are now required by law to inform parents about
the possible
dangers from an adverse reaction before giving the DPT
shot. In addition, in order to recognize a babies symptoms, the mother
can always ask a Doctor to provide a copy of the manufacturer’s product
information sheet included in every package of the vaccine as well as
verbally explain in grater detail the symptoms of the severe reactions,
such as convulsions, collapse, high fever and the steps one should be
taken if these symptoms are observed.
Vaccine Adverse Reporting System (VAERS) was set up for Doctor’s to
report adverse reactions to vaccines.
Monitoring System for Adverse Events Following Immunizations (MASEF) was
set up for public health clinic Doctor’s to report adverse reactions.
1987
HIB vaccine is licensed.
1988
The information insert placed in packages of DPT vaccine manufactured by
Lederle Laboratories stated: “pertussis vaccine has been associated with
a greater proportion of adverse reactions than many other childhood
diseases.”
The Vaccine Injury Compensation Act is funded.
The HIB vaccine is
added to the schedule for infants and children.
1989
International Workshop on Neurological Complications of Whooping Cough
and Pertussis Vaccine led by John Menkes MD, Professor Emergency of
Neurology and Pediatrics at UCLA. The consensus of scientists attending
was that, “there is sufficient data to implicate both endotoxin and
pertussis in neurological complications of the disease and in adverse
reactions to the pertussis vaccine.”
Italian parents refuse to allow the whole cell vaccine to be used on
their children due to reported side effects.
AAP and ACIP along with Lederle stated that convulsions occurring within
three days of a DPT shot were a contradiction to further pertussis
vaccine, although Connaught listed seven days. However, there are cases
in the scientific literature linking convulsions occurring up to two
weeks after the DPT shots to the pertussis vaccine.
CDC stated that, “that the chance of a child having a convulsion with
fever after receiving a DPT vaccine is up to nine times greater if a
child had a convulsion before.”
1990
United States Claims Court revealed that ninety two cases of vaccine
injury and death had
been decided under the National Vaccine Injury Act of 1986. More than
half the awards were made to parents whose children had died following
DPT vaccine reactions. Most of the children’s death certificates listed
cause of death as sudden infant death (SIDS).
The conjugate HIB vaccine
is licensed.
1991
Conjugated HIB was recommended and made available for use in infants as
young as two months.
1992
The AAP recommended the acelular pertussis vaccine for the 4th or 5th
doses only.
1993
The DPTH (DPT-Hib combo) vaccine was licensed.
1995
Iceland is the ONLY Western Europe country to require pertussis
immunization.
Varicella Vaccine licensed.
1996
Dtap licensed; recommended for use instead of whole-cell DPT
Hib-HepB combo vaccine is licensed
1998
Lyme vaccine (Lymerix) is licensed
Rotavirus vaccine is recommended by CDC for universal use in infants.
Rotavirus vaccine is licensed.
1999
Rotavirus vaccine pulled off the market due to significant adverse
reactions
1999/2000
A Joint Statement by the U.S. Public Health Service, the AAFP, the AAP,
and ACIP urging manufacturers to remove the preservative thimerosal as
soon as possible from vaccines routinely recommended for infants.
2000
Prevnar (pneumococcal conjugate vaccine) licensed.
CDC recommends use of IPV instead of OPV (polio vaccine).
2002
GSK pulled Lymerix off the market.
Pediarix (penta-valent DtaP/HepB/IPV) licensed.
CDC encourages flu vaccine for children.
2003
Inhaled flu vaccine (Flumist) being reviewed for approval by the FDA.
Smallpox vaccine for first-responders.

The Centers for Disease Control (CDC) and the FDA are supposed to work
together to protect the public health and safety by monitoring vaccine
reactions. The FDA tests vaccines for potency and toxicity, while the
CDC surveys the incidence of whooping cough in the country and collects
reports on vaccine reactions.
A “hot lot” is
defined as one that generates at least two reports of illness, seizures
or death. Reports are supposed to trigger an investigation of the
vaccine lot and withdrawal of one that appears to be especially toxic.
Lederle Lot number 585-61, distributed in 1980, met the “hot-lot”
criteria but was NOT withdrawn from circulation. It remained on the
market until all vials had been sold.
AND STILL WE CONTINUE TO VACCINATE?
[Reprinted and Updated
from TALK Newsletter, Vol. 5, Issue 5, 1996 with permission.]
GO TOP |
|
|